A UCC submission led by Dr Cora O’Neill, Director of the Cork NeuroScience Centre, has led to the Cork NeuroScience Centre being designated as a “Centre of Excellence in Neurodegeneration” (CoEN) after a national and international review process.
By gaining CoEN status, the Cork NeuroScience Centre joins a group of international centres eligible to apply for research funding awarded through the international CoEN initiative, including the next Pathfinder call.
This is a highly significant achievement for the Cork NeuroScience Centre giving international recognition to the high quality integrative multidisciplinary research in neurodegeneration in UCC.
Dr. O’Neill is very grateful to the teamwork, collaboration, input and support from all members of the Cork NeuroScience Centre and University which have enabled this very positive development. Other staff in the School participating in this initiative include Dr Paul Young, Dr Justin McCarthy and Prof Tom Cotter with Dr Tom Moore, Professor Rosemary O’Connor and Professor Mary McCaffrey as affiliated principal investigators.
Dr Cora O’Neill speaks at Gordon Research Conference on IGF-1 and insulin system in Physiology and Disease
Dr Cora O’Neill gave a talk entitled “Insulin and IGF-1 signalling system defects in Alzheimer’s disease: learning from this system in diabetes and cancer” at the recent Gordon Research Conference on IGF-1 and insulin system in Physiology and Disease held earlier this month in Ventura, California.
The 2015 Gordon Conference on the Insulin like Growth Factor (IGF) and insulin system in Physiology and Disease ran from March 8th-13th and presented cutting-edge research on the role of IGFs and insulin and their signalling pathways in normal growth, development, metabolism and in major diseases.